Form: 4

Statement of changes in beneficial ownership of securities

November 18, 2002

4: Statement of changes in beneficial ownership of securities

Published on November 18, 2002

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(h) of the Investment Company Act of 1940

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).

________________________________________________________________________________
1. Name and Address of Reporting Person*

S.A.C. Capital Management, LLC
- --------------------------------------------------------------------------------
(Last) (First) (Middle)

72 Cummings Point Road
- --------------------------------------------------------------------------------
(Street)

Stamford CT 06902
- --------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol

Sonus Pharmaceuticals, Inc. ("SNUS")
________________________________________________________________________________
3. IRS Identification Number of Reporting Person, if an entity (Voluntary)


________________________________________________________________________________
4. Statement for Month/Day/Year

11/18/2002
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Day/Year)


________________________________________________________________________________
6. Relationship of Reporting Person to Issuer
(Check all applicable)

[ ] Director [X] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)

------------------------
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check applicable line)

[X] Form filed by one Reporting Person
[ ] Form filed by more than one Reporting Person
________________________________________________________________________________
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================



5.
Amount of 6.
4. Securities Owner-
2. 2A. 3. Securities Acquired (A) or Beneficially ship
Trans- Deemed Trans- Disposed of (D) Owned Form: 7.
action Execution action (Instr. 3, 4 and 5) Following Direct Nature of
Date Date, if any Code ----------------------------- Reported (D) or Indirect
1. (Month/ (Month/ (Instr. 8) (A) Transaction(s) Indirect Beneficial
Title of Security Day/ Day/ ---------- Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) Year) Year) Code V (D) and 4) (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------

Common Stock, par value 11/14/02 P 72,600 A $1.7917 1,541,052 I (1)
$0.001 per share
- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================

(Over)




FORM 4 (continued)

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================


5. 7.
Number of Title and Amount
Derivative 6. of Underlying
4. Securities Date Securities
2. 3A. Trans- Acquired (A) Exercisable and (Instr. 3 and 4)
Conver- Deemed action or Disposed Expiration Date ----------------
1. sion or 3. Execution Code of(D) (Month/Day/Year) Amount
Title of Exercise Trans- Date, (Instr. (Instr. 3, ---------------- or
Derivative Price of action Date if any 8) 4 and 5) Date Expira- Number
Security Derivative (Month/ (Month/ ------ ------------ Exer- tion of
(Instr. 3) Security Day/Year) Day/Year) Code V (A) (D) cisable Date Title Shares
- ------------------------------------------------------------------------------------------------------------------------------------


- ------------------------------------------------------------------------------------------------------------------------------------

====================================================================================================================================

[TABLE CONTINUED BELOW]


[CONTINUATION OF TABLE FROM ABOVE]



9.
Number of 10.
Derivative Ownership
Securities Form of 11.
8. Beneficially Derivative Nature
Price of Owned Follow- Security of Indirect
Derivative ing Reported Direct (D) or Beneficial
Security Transaction(s) Indirect (I) Ownership
(Instr. 5) (Instr. 4) (Instr. 4) (Instr. 4)
- ---------------------------------------------------------


- ---------------------------------------------------------

=========================================================

Explanation of Responses:

(1) The securities to which this report relates are held by S.A.C. Capital Associates, LLC ("Associates") and S.A.C. Healthco Fund,
LLC ("Healthco"), limited liability companies of which the Reporting Person is an investment manager. Pursuant to investment
agreements, the Reporting Person shares all investment and voting power with respect to the securities held by Associates and
Healthco. In accordance with Instruction 4(b)(iv) the entire amount of the Issuer's securities held by Associates and Healthco is
reported herein. The transaction reported on herein was consummated by Associates. The Reporting Person disclaims any beneficial
ownership of any of the Issuer's securities to which this report relates for purposes of Section 16 of the Securities Exchange Act
of 1934, as amended, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an
admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.


/s/ Peter Nussbaum November 18, 2002
- --------------------------------------------- -----------------------
**Signature of Reporting Person Date

Peter Nussbaum
Authorized Person

Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.